insights_auto
Why is FBIO down 5.53%?
Dive Deeperchevron_right
FBIO:NASDAQ
Fortress Biotech Inc
$1.88
arrow_downward
-5.53%(-0.11) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FBIO...
Open
$1.92
High
$1.94
Low
$1.76
Mkt. cap
62.70M
Avg. vol.
234.54K
Volume
310.60K
P/E ratio
0.71
52-wk high
$4.53
52-wk low
$1.76
EPS
$2.65
Beta
1.27
Shares outstanding
33.35M
No. of employees
78
Open
$1.92
High
$1.94
Low
$1.76
Mkt. cap
62.70M
Avg. vol.
234.54K
Volume
310.60K
P/E ratio
0.71
52-wk high
$4.53
52-wk low
$1.76
EPS
$2.65
Beta
1.27
Shares outstanding
33.35M
No. of employees
78
News stories
From web sources and news partners
GuruFocus
·
1 day ago
Fortress Biotech Inc Reports Q3 2026 Results: Revenue of $19.2 M
Investing.com
·
1 day ago
Fortress Biotech earnings missed by $0.08, revenue fell short of estimates
Investing.com Canada
·
1 day ago
Form 8K Fortress Biotech Inc For: 13 November By Investing.com
www.marketscreener.com
·
1 day ago
Fortress Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitefortressbiotech.com